Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Federal Trade Commission v. Shire ViroPharma Inc.
Case Number:
1:17-cv-00131
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
September 25, 2018
Sham Petition Suits Are Piercing Big Pharma's Antitrust Shield
A long-standing U.S. Supreme Court doctrine shielding companies that petition the U.S. Food and Drug Administration from antitrust liability is proving increasingly unhelpful to brand-name drugmakers accused of delaying generic-drug rivals by bombarding the FDA with cockamamie scientific arguments.
-
April 11, 2018
FTC Appeals Big Loss To A Shire Unit In Sham Petition Case
The Federal Trade Commission on Wednesday appealed its stinging loss to Shire ViroPharma Inc. in a landmark case that alleges abuse of the U.S. Food and Drug Administration's citizen petition process to delay competition from generic drugs.
-
March 22, 2018
FTC's Big ViroPharma Loss Has Antitrust Silver Lining
The Federal Trade Commission suffered a big setback when a Delaware federal judge axed its milestone challenge to ViroPharma Inc.'s anti-generic maneuvering, but the agency simultaneously notched a victory that will impede drugmakers from quickly beating similar challenges in the future.
-
March 20, 2018
FTC Loses Assault On Shire Unit's Serial FDA Petitions
The Federal Trade Commission on Tuesday lost its first-ever legal assault on drugmaker efforts to delay generic competition by constantly petitioning the U.S. Food and Drug Administration, even as a Delaware federal judge identified potential antitrust violations by Shire PLC unit ViroPharma Inc.
-
April 10, 2017
Shire Scorches FTC Suit Over Anti-Generic Petitions
Shire ViroPharma Inc. on Monday hammered a Federal Trade Commission antitrust suit over alleged abuse of the U.S. Food and Drug Administration's citizen petition process to delay generic competition, calling it procedurally improper and an affront to constitutional rights.
-
February 08, 2017
What To Watch As FTC Opens New Front On Generic Delays
The Federal Trade Commission's first-of-its-kind lawsuit alleging abuse of the U.S. Food and Drug Administration's citizen petition process will shed light on when drugmaker efforts to delay generic competition cross a blurry line between free speech and obstruction, experts say.
-
February 07, 2017
Shire Unit Abused FDA Process With Most Filings Ever: FTC
A unit of Shire PLC was hit with a suit Tuesday by the Federal Trade Commission accusing the company of clogging the approval pipeline for a generic version of its gastrointestinal infection treatment with a record number of filings that delayed approval by two years.